Nurexone’s Strategic Update: Submission of OTCQB Listing Application to Initiate US Financial Presence
NurExone Biologic, a pioneering biopharmaceutical company, developing regenerative medicine therapies, announces its intention to broaden its market reach through a recently filed application for listing on the OTCQB Venture Market (the “OTCQB”) in the United States. Listing on the OTCQB is subject to approval of the OTC Markets Group. The......